Brief: Clearmind Medicine Announces Filing Of European Patent Application For Novel Psychedelic Compounds For The Treatment Of Ptsd
05/05/2026 13:53
May 5 (Reuters) - Clearmind Medicine Inc CMND.O: CLEARMIND MEDICINE ANNOUNCES FILING OF EUROPEAN PATENT APPLICATION FOR NOVEL PSYCHEDELIC COMPOUNDS FOR THE TREATMENT OF PTSD Source text: ID:nGNXc7nprj Further company coverage: CMND.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearmind Medicine
See all newsBrief: Clearmind Advances Dialogue With U.S. Federal Government On Psychedelic Therapies, Submitting Recommendations To FDA
NASDAQ RESUMED AT 09:00 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM
NASDAQ TRADE HALT CONTINUES HALT NEWS PENDING AT 03:28 AM